泌汗功能障碍独立预测2型糖尿病心肾事件及全因死亡
结果显示,ESC复合评分低者发生慢性肾脏病和心血管疾病的风险显著增加,且独立于常见风险标志物。
要点
- ESC复合评分每降低1单位,慢性肾脏病风险增加2%,心血管疾病和全因死亡风险各增加4%。
- 将ESC复合评分加入临床变量可改善所有结局的区分度并对慢性肾脏病风险进行适当重分类。
核心结论
- 低ESC复合评分独立预测2型糖尿病患者的突发心血管-肾脏事件和死亡。
研究设计与样本
- 前瞻性队列研究,纳入2833名中国2型糖尿病成人进行结构化评估,其中2028名无心血管疾病和慢性肾脏病者随访至2015年,中位随访2.3年。
主要发现
- 随访期间163名(8.0%)发生慢性肾脏病,25名(1.2%)发生心血管疾病。
- ESC复合评分每降低1单位,慢性肾脏病、心血管疾病和全因死亡的调整风险比分别为1.02(95%CI 1.01-1.04)、1.04(1.00-1.07)和1.04(1.00-1.08)。
- 与ESC复合评分>53者相比,评分≤53者慢性肾脏病的调整风险比为1.56(95%CI 1.09-2.23),心血管疾病为3.11(95%CI 1.27-7.62)。
- 将ESC复合评分加入临床变量(性别和糖尿病病程)后,改善了所有结局的区分度并对慢性肾脏病风险进行了适当重分类。
关键数值与推荐
- ESC复合评分≤53定义为泌汗功能障碍,该阈值用于风险分层。
临床怎么用
- 在2型糖尿病评估中,可考虑使用SUDOSCAN测量的ESC复合评分来识别心肾事件高风险患者,以优化早期干预筛查策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early detection and risk factor control prevent chronic kidney disease (CKD) progression. Evaluation of peripheral autonomic dysfunction may detect incident cardiovascular-renal events in type 2 diabetes (T2D). METHODS: SUDOSCAN, a non-invasive tool, provides an age-adjusted electrochemical skin conductance (ESC) composite score incorporating hands/feet ESC measurements, with a score ≤53 indicating sudomotor dysfunction. A consecutive cohort of 2833 Chinese adults underwent structured diabetes assessment in 2012-13; 2028 participants without preexisting cardiovascular disease (CVD) and CKD were monitored for incident cardiovascular-renal events until 2015. RESULTS: In this prospective cohort {mean age 57.0 [standard deviation (SD) 10.0] years; median T2D duration 7.0 [interquartile range (IQR) 3.0-13.0] years; 56.1% men; 72.5% never-smokers; baseline ESC composite score 60.7 (SD 14.5)}, 163 (8.0%) and 25 (1.2%) participants developed incident CKD and CVD, respectively, after 2.3 years of follow-up. The adjusted hazard ratios (aHRs) per 1-unit decrease in the ESC composite score for incident CKD, CVD and all-cause death were 1.02 [95% confidence interval (CI) 1.01-1.04], 1.04 (1.00-1.07) and 1.04 (1.00-1.08), respectively. Compared with participants with an ESC composite score >53, those with a score ≤53 had an aHR of 1.56 (95% CI 1.09-2.23) for CKD and 3.11 (95% CI 1.27-7.62) for CVD, independent of common risk markers. When added to clinical variables (sex and duration of diabetes), the ESC composite score improved discrimination of all outcomes with appropriate reclassification of CKD risk. CONCLUSIONS: A low ESC composite score independently predicts incident cardiovascular-renal events and death in T2D, which may improve the screening strategy for early intervention.
引用
- Lim LL, Fu AWC, Lau ESH, et al. Sudomotor dysfunction independently predicts incident cardiovascular-renal events and all-cause death in type 2 diabetes: the Joint Asia Diabetes Evaluation register. Nephrol Dial Transplant. 2019. PMID: 29939305. doi:10.1093/ndt/gfy154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。